16-80612634-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_152342.4(CDYL2):c.1210G>A(p.Val404Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000523 in 1,606,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V404F) has been classified as Uncertain significance.
Frequency
Consequence
NM_152342.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDYL2 | NM_152342.4 | c.1210G>A | p.Val404Ile | missense_variant | Exon 5 of 7 | ENST00000570137.7 | NP_689555.2 | |
CDYL2 | XM_011522866.2 | c.1312G>A | p.Val438Ile | missense_variant | Exon 5 of 7 | XP_011521168.1 | ||
CDYL2 | XM_011522867.3 | c.1201G>A | p.Val401Ile | missense_variant | Exon 5 of 7 | XP_011521169.1 | ||
CDYL2 | XM_024450151.2 | c.1033G>A | p.Val345Ile | missense_variant | Exon 5 of 7 | XP_024305919.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000204 AC: 5AN: 245206Hom.: 0 AF XY: 0.0000302 AC XY: 4AN XY: 132420
GnomAD4 exome AF: 0.0000536 AC: 78AN: 1454540Hom.: 0 Cov.: 31 AF XY: 0.0000498 AC XY: 36AN XY: 723226
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152118Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1210G>A (p.V404I) alteration is located in exon 5 (coding exon 5) of the CDYL2 gene. This alteration results from a G to A substitution at nucleotide position 1210, causing the valine (V) at amino acid position 404 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at